Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase-Deficient Renal Cell Carcinoma.
贝伐珠单抗和厄洛替尼在肾髓质癌和富马酸水合酶缺乏型肾细胞癌临床前模型中的差异疗效
期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-24-0703
Zacharias Niki M, Ozambela Manuel, Karki Menuka, He Rong, Chauhan Pankaj K, Pesquera Pedro I, Hernandez Gonzalez Andres E, Ochoa Oscar, Pieretti Alberto, Chen Huiqin, De La Cerda Carolyn, Yu Zhiyuan, Grover Abha, Hicks-Peña Samantha, Fowlkes Natalie W, Wang Lei, Maity Tapati, Rao Priya, Genovese Giannicola, Tannir Nizar M, Karam Jose A, Msaouel Pavlos
